OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
33 hedge funds and large institutions have $22.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.3M | |
| 2 | +$1.83M | |
| 3 | +$1.01M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$517K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$247K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$428K | |
| 3 | -$345K | |
| 4 |
B
Bailard
Foster City,
California
|
-$322K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$291K |